New insights into the pathogenesis of IgA nephropathy

Seminars in Immunopathology

Volumn 36, Issue 4, 2014, Pages 431-442

  Floege, Jürgen ^a   Moura, Ivan C ^b,c   Daha, Mohamed R ^d  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD89; Complement; IgA nephropathy; IgA receptor; Mesangium; PDGF; Transferrin receptor 1

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A RECEPTOR; IMMUNOGLOBULIN RECEPTOR; UNCLASSIFIED DRUG; CD71 ANTIGEN; COMPLEMENT; FC RECEPTOR; FC(ALPHA) RECEPTOR; IMMUNOGLOBULIN A; LEUKOCYTE ANTIGEN; PLATELET DERIVED GROWTH FACTOR; TRANSFERRIN RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; CAUSAL ATTRIBUTION; COMPLEMENT ACTIVATION; DISEASE MODEL; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GLOMERULOPATHY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOGENESIS; KIDNEY SCAR; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN GLYCOSYLATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; GLOMERULUS FILTRATION RATE; IMMUNOLOGY; KIDNEY; PATHOLOGY;

ANTIGENS, CD; COMPLEMENT SYSTEM PROTEINS; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KIDNEY; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, FC; RECEPTORS, TRANSFERRIN;

EID: 84905920413     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-013-0411-7     Document Type: Review

References (85)

1. Tiebosch AT, Wolters J, Frederik PF, van der Wiel TW, Zeppenfeldt E, van Breda Vriesman PJ (1987) Epidemiology of idiopathic glomerular disease: a prospective study. Kidney Int 32:112-116 (Pubitemid 17094506)
2. Waldherr R, Rambausek M, Duncker WD, Ritz E (1989) Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant 4:943-946 (Pubitemid 20050397)
3. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y (2003) Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63:2286-2294 (Pubitemid 36605844)
4. Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK (2001) The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med 110:434-437
5. Gutierrez E, Zamora I, Ballarin JA, Arce Y, Jimenez S, Quereda C, Olea T,Martinez-Ara J, Segarra A, Bernis C, Garcia A, Goicoechea M, Garcia de Vinuesa S, Rojas-Rivera J, Praga M (2012) Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 23:1753-1760
6. Floege J (2004) Recurrent IgA nephropathy after renal transplantation. Semin Nephrol 24:287-291
7. Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L (2011) Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol 22:752-761
8. Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezene F, Berthoux F (2001) Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37:720-727 (Pubitemid 32268032)
9. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schafer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P (1998) Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54:926-931 (Pubitemid 28397411)
10. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546-556
11. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D 'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B,Mezzano S, Schena FP, TominoY, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534-545
12. Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C (2011) The use of the Oxford classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol 6:2384-2388
13. Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC (2011) Validation of the Oxford classification of IgA nephropathy. Kidney Int 80:310-317
14. Kang SH, Choi SR, Park HS, Lee JY, Sun IO, Hwang HS, Chung BH, Park CW, Yang CW, Kim YS, Choi YJ, Choi BS (2012) The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant 27:252-258
15. Katafuchi R, Ninomiya T, Nagata M, Mitsuiki K, Hirakata H (2011) Validation study of Oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrol 6:2806-2813
16. Lv J, Shi S, Xu D, Zhang H, Troyanov S, Cattran DC, Wang H (2013) Evaluation of the Oxford classification of IgA nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 62:891-899
17. Mubarak M (2012) Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant 27:2998-2999, author reply 2999-3000
18. Troyanov S, Fervenza FC (2011) Validating the Oxford classification of IgA nephropathy. Clin J Am Soc Nephrol 6:2335-2336
19. Zeng CH, Le W, Ni Z, Zhang M, Miao L, Luo P, Wang R, Lv Z, Chen J, Tian J, Chen N, Pan X, Fu P, Hu Z,Wang L, Fan Q, Zheng H, Zhang D, Wang Y, Huo Y, Lin H, Chen S, Sun S, Liu Z, Liu D, Ma L, Pan T, Zhang A, Jiang X, Xing C, Sun B, Zhou Q, Tang W, Liu F, Liu Y, Liang S, Xu F, Huang Q, Shen H, Wang J, Shyr Y, Phillips S, Troyanov S, Fogo A, Liu ZH (2012) A multicenter application and evaluation of the Oxford classification of IgA nephropathy in adult Chinese patients. Am J Kidney Dis 60:812-820
20. Liu H, Peng Y, Liu Y, Yuan S, Liu F, Yang D, Chen X, He L, Fu M, Shao J, Yang L (2012) Renal biopsy findings of patients presenting with isolated hematuria: disease associations. Am J Nephrol 36:377-385
21. Yu XQ, Li M, Zhang H, Low HQ, Wei X, Wang JQ, Sun LD, Sim KS, LiY, Foo JN,WangW, Li ZJ,YinXY, TangXQ, Fan L, Chen J, Li RS,Wan JX, Liu ZS, Lou TQ, Zhu L, Huang XJ, Zhang XJ, Liu ZH, Liu JJ (2012) A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet 44:178-182
22. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, Novak J, He JC, Wang H, Lv J, Zhu L, Wang W, Wang Z, Yasuno K, Gunel M, Mane S, Umlauf S, Tikhonova I, Beerman I, Savoldi S, Magistroni R, Ghiggeri GM, Bodria M, Lugani F, Ravani P, Ponticelli C, Allegri L, Boscutti G, Frasca G, Amore A, Peruzzi L, Coppo R, Izzi C, Viola BF, Prati E, Salvadori M, Mignani R, Gesualdo L, Bertinetto F, Mesiano P, Amoroso A, Scolari F, Chen N, Zhang H, Lifton RP (2011) Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43:321-327
23. Monteiro RC (2007) Pathogenic role of IgA receptors in IgA nephropathy. Contrib Nephrol 157:64-69
24. Rifai A, Small PA Jr, Teague PO, Ayoub EM (1979) Experimental IgA nephropathy. J Exp Med 150:1161-1173 (Pubitemid 10249941)
25. Monteiro RC, Halbwachs-Mecarelli L, Berger J, Lesavre P (1984) Characteristics of eluted IgA in primary IgA nephropathy. Contrib Nephrol 40:107-111
26. Emancipator SN, Gallo GR, Lamm ME (1983) Experimental IgA nephropathy induced by oral immunization. J Exp Med 157:572-582 (Pubitemid 13145060)
27. Layward L, Allen AC, Hattersley JM, Harper SJ, Feehally J (1995) Response to mucosal antigen challenge in IgA nephropathy. Exp Nephrol 3:300-307
28. Smith AC, Molyneux K, Feehally J, Barratt J (2006) Oglycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 17:3520-3528 (Pubitemid 44865295)
29. Imai H, Nakamoto Y, Asakura K, Miki K, Yasuda T, Miura AB (1985) Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 27:756-761 (Pubitemid 15064635)
30. Okazaki K, Suzuki Y, Otsuji M, Suzuki H, Kihara M, Kajiyama T, Hashimoto A, Nishimura H, Brown R, Hall S, Novak J, Izui S, Hirose S, Tomino Y (2012) Development of a model of early-onset IgA nephropathy. J Am Soc Nephrol 23:1364-1374
31. Gesualdo L, Ricanati S, Hassan MO, Emancipator SN, Lamm ME (1990) Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy. J Clin Invest 86:715-722 (Pubitemid 20327358)
32. Lamm ME, Emancipator SN, Robinson JK, Yamashita M, Fujioka H, Qiu J, Plaut AG (2008) Microbial IgA protease removes IgA immune complexes frommouse glomeruli in vivo: potential therapy for IgA nephropathy. Am J Pathol 172:31-36 (Pubitemid 351186365)
33. Berger J, Yaneva H, Nabarra B, Barbanel C (1975) Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 7:232-241
34. Zheng F, Kundu GC, Zhang Z, Ward J, DeMayo F, Mukherjee AB (1999) Uteroglobin is essential in preventing immunoglobulin a nephropathy in mice. Nat Med 5:1018-1025 (Pubitemid 29439572)
35. Wang J, Anders RA,Wu Q, Peng D, Cho JH, Sun Y, Karaliukas R, Kang HS, Turner JR, Fu YX (2004) Dysregulated light expression on T-cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest 113:826-835 (Pubitemid 38544141)
36. McCarthyDD, Kujawa J,Wilson C, Papandile A, Poreci U, Porfilio EA, Ward L, Lawson MA, Macpherson AJ, McCoy KD, Pei Y, Novak L, Lee JY, Julian BA, Novak J, Ranger A, Gommerman JL, Browning JL (2011) Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest 121:3991-4002
37. Otani M, Nakata J, Kihara M, Leroy V, Moll S, Wada Y, Izui S (2012) O-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis. J Am Soc Nephrol 23:438-446
38. Monteiro RC (2005) New insights in the pathogenesis of IgA nephropathy. Nefrologia 25(Suppl 2):82-86
39. Kanamaru Y, Arcos-FajardoM, Moura IC, Tsuge T, Cohen H, Essig M, Vrtovsnik F, Loirat C, Peuchmaur M, Beaudoin L, Launay P, Lehuen A, Blank U, Monteiro RC (2007) Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor. Eur J Immunol 37:1116-1128 (Pubitemid 46925347)
40. Duchez S, Amin R, Cogne N, Delpy L, Sirac C, Pascal V, Corthesy B, Cogne M (2010) Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation. Proc Natl Acad Sci U S A 107:3064-3069
41. Coulon S, Dussiot M, Grapton D, Maciel TT, Wang PH, Callens C, Tiwari MK, Agarwal S, Fricot A, Vandekerckhove J, Tamouza H, Zermati Y, Ribeil JA, Djedaini K, Oruc Z, Pascal V, Courtois G, Arnulf B, AlyanakianMA,Mayeux P, Leanderson T, BenhamouM, Cogne M, Monteiro RC, Hermine O, Moura IC (2011) Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia. Nat Med 17:1456-1465
42. Berthelot L, Papista C, Maciel TT, Biarnes-Pelicot M, Tissandie E, Wang PH, Tamouza H, Jamin A, Bex-Coudrat J, Gestin A, Boumediene A, Arcos-Fajardo M, England P, Pillebout E, Walker F, Daugas E, Vrtosvnik F, Flamant M, Benhamou M, Cogne M, Moura IC, Monteiro RC (2012) Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 209:793-806
43. Gharavi AG, Yan Y, Scolari F, Schena FP, Frasca GM, Ghiggeri GM, Cooper K, Amoroso A, Viola BF, Battini G, Caridi G, Canova C, Farhi A, SubramanianV, Nelson-Williams C,Woodford S, Julian BA, Wyatt RJ, Lifton RP (2000) IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26:354-357
44. Suzuki H, Suzuki Y, Yamanaka T, Hirose S, Nishimura H, Toei J, Horikoshi S, Tomino Y (2005) Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human igan1 on chromosome 6q22-23. J Am Soc Nephrol 16:1289-1299 (Pubitemid 41716513)
45. Liu XQ, Paterson AD, He N, St George-Hyslop P, Rauta V, Gronhagen-Riska C, Laakso M, Thibaudin L, Berthoux F, Cattran D, Pei Y (2008) Il5ra and tnfrsf6b gene variants are associated with sporadic IgA nephropathy. J Am Soc Nephrol 19:1025-1033
46. Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, Snyder HJ, Choi M, Hou P, Scolari F, Izzi C, Gigante M, Gesualdo L, Savoldi S, Amoroso A, Cusi D, Zamboli P, Julian BA, Novak J,Wyatt RJ,MuchaK, PerolaM, Kristiansson K,Viktorin A, Magnusson PK, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boland A, Metzger M, Thibaudin L, Wanner C, Jager KJ, Goto S, Maixnerova D, Karnib HH, Nagy J, Panzer U, Xie J, Chen N, Tesar V, Narita I, Berthoux F, Floege J, Stengel B, Zhang H, Lifton RP, Gharavi AG (2012) Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet 8:e1002765
47. Bertinetto FE, Calafell F, Roggero S, Chidichimo R, Garino E, Marcuccio C, Coppo R, Scolari F, Frasca GM, Savoldi S, Schena FP, Amoroso A (2012) Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3. Nephrol Dial Transplant 27:2328-2337
48. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, Mestecky J, Novak J, Julian BA (2008) Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19:1008-1014
49. Johnson RJ, Hurtado A, Merszei J, Rodriguez-Iturbe B, Feng L (2003) Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide. Am J Kidney Dis 42:575-581
50. Tissandie E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawale JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC (2011) Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int 80:1352-1363
51. Coppo R, Camilla R, Amore A, Peruzzi L, Dapra V, Loiacono E, Vatrano S, Rollino C, Sepe V, Rampino T, Dal Canton A (2010) Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin a nephropathy. Clin Exp Immunol 159:73-81
52. Trascasa ML, Egido J, Sancho J, Hernando L (1980) IgA glomerulonephritis (Berger 's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol 42:247-254 (Pubitemid 10008791)
53. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P (1985) Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28:666-671 (Pubitemid 16205803)
54. Andre PM, Le Pogamp P, Chevet D (1990) Impairment of jacalin binding to serumIgA in IgA nephropathy. J Clin Lab Anal 4:115-119
55. Hiki Y, Iwase H, Kokubo T, Horii A, Tanaka A, Nishikido J, Hotta K, Kobayashi Y (1996) Association of asialo-galactosyl beta 1-3nacetylgalactosamine on the hinge with a conformational instability of jacalin-reactive immunoglobulin a1 in immunoglobulin a nephropathy. J Am Soc Nephrol 7:955-960 (Pubitemid 27465991)
56. HikiY, Iwase H, Saitoh M, Saitoh Y, HoriiA,Hotta K, Kobayashi Y (1996) Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy. Nephron 72:429-435 (Pubitemid 26059575)
57. Woof JM, Russell MW (2011) Structure and function relationships in IgA. Mucosal Immunol 4:590-597
58. Novak J, Renfrow MB, Gharavi AG, Julian BA (2013) Pathogenesis of immunoglobulin A nephropathy. Curr Opin Nephrol Hypertens. doi:10.1097/MNH. 0b013e32835fef54
59. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73-81 (Pubitemid 29534347)
60. Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J (1999) Analysis of IgA1 o-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 10:1763-1771 (Pubitemid 29364675)
61. Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K (2001) Mass spectrometry proves under-o-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59:1077-1085 (Pubitemid 32206870)
62. Coppo R, Amore A (2004) Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65:1544-1547 (Pubitemid 38590997)
63. Xu LX, Zhao MH (2005) Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int 68:167-172
64. Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71:1148-1154 (Pubitemid 46809135)
65. Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J (2005) Determination of aberrant o-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform-ion cyclotron resonance mass spectrometry. J Biol Chem 280:19136-19145 (Pubitemid 41379620)
66. Franc V, Rehulka P, Raus M, Stulik J, Novak J, Renfrow MB, Sebela M (2013) Elucidating heterogeneity of IgA1 hinge-region o-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing. J Proteomics 92:299-312
67. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, Alarcon GS, Kimberly RP, Tomino Y, Mestecky J, Novak J (2008) IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 118:629-639 (Pubitemid 351206552)
68. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, Feehally J (2001) Mesangial IgA1 in IgA nephropathy exhibits aberrant oglycosylation: observations in three patients. Kidney Int 60:969-973 (Pubitemid 34205796)
69. Zhao N, Hou P, Lv J, Moldoveanu Z, Li Y, Kiryluk K, Gharavi AG, Novak J, Zhang H (2012) The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int 82:790-796
70. Berthoux F, Suzuki H, Thibaudin L, Yanagawa H, Maillard N, Mariat C, Tomino Y, Julian BA, Novak J (2012) Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 23:1579-1587
71. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J (2009) Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119:1668-1677
72. Tamouza H, Chemouny JM, Raskova Kafkova L, Berthelot L, Flamant M, Demion M, Mesnard L, Paubelle E, Walker F, Julian BA, Tissandie E, Tiwari MK, Camara NO, Vrtovsnik F, Benhamou M, Novak J, Monteiro RC, Moura IC (2012) The IgA1 immune complex-mediated activation of theMAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy. Kidney Int 82:1284-1296
73. Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J (2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67:504-513 (Pubitemid 40139842)
74. Monteiro RC,Moura IC, Launay P, Tsuge T, Haddad E, Benhamou M, Cooper MD, Arcos-Fajardo M (2002) Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med 8: 464-468
75. Monteiro RC, Van De Winkel JG (2003) IgA Fc receptors. Annu Rev Immunol 21:177-204 (Pubitemid 37174530)
76. Baumann J, Park CG, Mantis NJ (2010) Recognition of secretory IgA by dc-sign: implications for immune surveillance in the intestine. Immunol Lett 131:59-66
77. Diana J, Moura IC, Vaugier C, Gestin A, Tissandie E, Beaudoin L, Corthesy B, Hocini H, Lehuen A, Monteiro RC (2013) Secretory IgAinduces tolerogenic dendritic cells through SIGNR1 dampening autoimmunity in mice. J Immunol 191:2335-2343
78. Mestecky J, Russell MW (1986) IgA subclasses. Monogr Allergy 19:277-301
79. Herr AB, Ballister ER, Bjorkman PJ (2003) Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 423:614-620 (Pubitemid 36713216)
80. Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, Merger M, Sellers MT, Orenstein JM, Shimada T, Graham MF, Kubagawa H (2001) Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 167:2651-2656 (Pubitemid 32768894)
81. Schlondorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20:1179-1187
82. Leung JC, Tsang AW, Chan DT, Lai KN (2000) Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J Am Soc Nephrol 11:241-249 (Pubitemid 30064847)
83. McDonald KJ, Cameron AJ, Allen JM, Jardine AG (2002) Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. Biochem Biophys Res Commun 290:438-442 (Pubitemid 34694519)
84. Moura IC, Benhamou M, Launay P, Vrtovsnik F, Blank U, Monteiro RC (2008) The glomerular response to IgA deposition in IgA nephropathy. Semin Nephrol 28:88-95
85. Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, Cooper MD, Monteiro RC (2001) Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 194:417-425 (Pubitemid 32835038)